 | Articles: Chemotherapy/Oncology |
Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis
Journal of Clinical Oncology, 07/11/08
The aromatase inhibitor letrozole and IGF-IR inhibitors synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer
Breast Cancer Research, 07/11/08
Curcumin and cancer: An "old-age" disease with an "age-old" solution
Cancer Letters, 07/11/08
 | | Sponsor |
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia - Cancer and leukemia group B study 10107
Leukemia and Lymphoma, 07/11/08
Thalidomide and lenalidomide: Mechanism-based potential drug combinations
Leukemia and Lymphoma, 07/11/08
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Carcinogenesis, 07/10/08
Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia
Modern Pathology, 07/10/08
Transporter-Mediated Protection against Thiopurine-Induced Hematopoietic Toxicity
Cancer Research, 07/10/08
Phosphatidylinositol 3-kinase inhibitors: promising drug candidates for cancer therapy
Cancer Science, 07/10/08
Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells
Anti-Cancer Drugs, 07/09/08
|
 Receive daily email updates on Chemotherapy/Oncology
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
|
